NASDAQ
Lixte Biotechnology Holdings, Inc. (LIXT) has a free cash flow growth of -70.62% as of Friday, May 29, 2026. This represents a 220.27% decrease compared to its 12-month average of -22.05%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.